University of Louisville School of Medicine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
University of Louisville School of Medicine
Jun 26, 2024, 10:24 |
Blog
Chandler Park: Which patients would you not give EV-Pembro for 1st line metastatic bladder cancer?
Chandler Park shared on X: . "Which patients would…
Jun 22, 2024, 04:30 |
Insight
Chandler Park: Best things about ASCO24
Chandler Park shared on LinkedIn: “Best things about ASCO24 is learning new cancer information to…
Jun 6, 2024, 00:32 |
Blog
Chandler Park: Mentor and Mentee Moment at ASCO24
Chandler Park shared a post on LinkedIn: . "Mentor and Mentee Moment at…
May 26, 2024, 05:48 |
Blog
Top 10 ASCO24 Developmental Therapeutics Molecularly Targeted Agents Abstracts by Bruno Bastos
Chandler Park shared a post by Bruno Bastos, certified Hematologist/Oncologist at Baptist Health South Florida, on X/Twitter:…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube